2018 Speakers

 
 
 

Dirar Abdallah, Consultant Internal Medicine, Prime Hospital

Dirar Abdallah at World Anti-Microbial Resistance Congress 2018

Dirar Abdullah, Head, Adult Critical Care Services, Chair, Antibiotic Committee and Antibiotic Stewardship Program, Prime Hospital- Dubai

Dirar Abdullah at World Anti-Microbial Resistance Congress 2018

Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organisation

Dr Tedros Adhanom Ghebreyesus at World Anti-Microbial Resistance Congress 2018

Nicholas Adomakoh, Global Medical Affairs Lead for Anti-infectives, Sandoz International GmbH

Nicholas Adomakoh at World Anti-Microbial Resistance Congress 2018

Brian Michael Aldridge, Clinical Professor, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine

Brian Michael Aldridge at World Anti-Microbial Resistance Congress 2018

Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Javad Aman at World Anti-Microbial Resistance Congress 2018

Christine Årdal, Senior Advisor, Norwegian Institute of Public Health

Christine Årdal at World Anti-Microbial Resistance Congress 2018

Paul Auwaerter, President, Infectious Diseases Society of America IDSA

Paul Auwaerter at World Anti-Microbial Resistance Congress 2018

Thierry Bernardi, CEO, Biofilm Pharma

Thierry Bernardi at World Anti-Microbial Resistance Congress 2018

Susan Casey Bleasdale, Medical Director Infection Prevention & Control and Antimicrobial Stewardship, University of Illinois Hospital & Health Sciences System

Susan Casey Bleasdale at World Anti-Microbial Resistance Congress 2018

Gabrielle Breugelmans, Director of Research, Access to Medicine Foundation

Gabrielle Breugelmans at World Anti-Microbial Resistance Congress 2018

Nancy Caralla, Founding President and Executive Director, C Diff Foundation

Nancy Caralla at World Anti-Microbial Resistance Congress 2018

Paul Carlson, Principal investigator, Laboratory of Mucosal Pathogens and Cellular Immunology, FDA

Paul Carlson at World Anti-Microbial Resistance Congress 2018

Cornelius J. (Neil) Clancy, Associate Professor of Medicine, Infectious Diseases Division, and Director, Mycology Program, University of Pittsburgh

Cornelius J. (Neil) Clancy at World Anti-Microbial Resistance Congress 2018

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Timothy Cooke at World Anti-Microbial Resistance Congress 2018

Sanjeet Dadwal, Associate Clinical Professor Head of Antimicrobial Stewardship Program, City Of Hope National Medical Center

Sanjeet Dadwal at World Anti-Microbial Resistance Congress 2018

Glenn Dale, Head of Early Development, Antimicrobials, Polyphor Ltd

Glenn Dale at World Anti-Microbial Resistance Congress 2018

Gregory Daniel, Deputy Director, Duke University

Gregory Daniel at World Anti-Microbial Resistance Congress 2018

Lisa Davidson, Medical Director, Antimicrobial Support Network, Atrium Health

Lisa Davidson at World Anti-Microbial Resistance Congress 2018

Sarah Doernberg, Associate Professor, University of California, San Francisco

Sarah Doernberg at World Anti-Microbial Resistance Congress 2018

Michael Dudley, Senior Vice President and Chief Scientific Officer, Qpex Biopharma

Michael Dudley at World Anti-Microbial Resistance Congress 2018

Stuart Andrew Edwardson, Clinical Scientist, Proteus

Stuart Andrew Edwardson at World Anti-Microbial Resistance Congress 2018

Barry Eisenstein, Chair, Scientific Advisory Board, CARB-X

Barry Eisenstein at World Anti-Microbial Resistance Congress 2018

Mark Engel, CEO, Phagelux

Mark Engel at World Anti-Microbial Resistance Congress 2018

Sandy Estrada, Director Clinical Affairs, T2 Biosystems Inc

Sandy Estrada at World Anti-Microbial Resistance Congress 2018

Olivier Favre Bulle, Founder and Consultant in Drug Development and Business Strategy, 3Biotech

Olivier Favre Bulle at World Anti-Microbial Resistance Congress 2018

Greg Frank, Director, Infectious Disease Policy, BIO

Greg Frank at World Anti-Microbial Resistance Congress 2018

Kuntal Ganguly, Lead Scientist - Formulation and Development, Venus Remedies Limited

Kuntal Ganguly at World Anti-Microbial Resistance Congress 2018

Steven Gilman, Chief Executive Officer, Contrafect Corporation

Steven Gilman at World Anti-Microbial Resistance Congress 2018

Marc Gitzinger, Chief Executive Officer And Co-Founder, Bioversys

Marc Gitzinger at World Anti-Microbial Resistance Congress 2018

Debra Goff, Infectious Diseases Specialist,The Ohio State University Wexner Medical Center Clinical Associate Pr, Ohio State University Medical Center

Debra Goff at World Anti-Microbial Resistance Congress 2018

Tina Guina, CARB-X Program Manager, BARDA

Tina Guina at World Anti-Microbial Resistance Congress 2018

Rana Hamdy, Director, Antimicrobial Stewardship Program, Children's National Health System

Rana Hamdy at World Anti-Microbial Resistance Congress 2018

Benjamin Hammer, Co-leader of the Antimicrobial Stewardship Program, Children's National Health System

Benjamin Hammer at World Anti-Microbial Resistance Congress 2018

Janet Hammond, Vice President Infectious Diseases, AbbVie

Janet Hammond at World Anti-Microbial Resistance Congress 2018

Elizabeth Hermsen, Head, Global Antimicrobial Stewardship, Merck & Co., Inc.

Elizabeth Hermsen at World Anti-Microbial Resistance Congress 2018

Silas Holland, Director of Infectious Disease Policy, Merck & Co

Silas Holland at World Anti-Microbial Resistance Congress 2018

Chris Houchens, Health Scientist, BARDA

Chris Houchens at World Anti-Microbial Resistance Congress 2018

David Huang, Chief Medical Officer, Motif Bio

David Huang at World Anti-Microbial Resistance Congress 2018

Dmitri Iarikov, Deputy Director in the Division of Anti-Infective Products, FDA

Dmitri Iarikov at World Anti-Microbial Resistance Congress 2018

Peter Jackson, CEO, The AMR Centre UK

Peter Jackson at World Anti-Microbial Resistance Congress 2018

Amanda Jezek, Senior VP, Public Policy and Government Relations, Infectious Diseases Society of America

Amanda Jezek at World Anti-Microbial Resistance Congress 2018

Eugean Jiwanmall, Senior Research Analyst, Technology Evaluation & Medical Policy, Independence Blue Cross

Eugean Jiwanmall at World Anti-Microbial Resistance Congress 2018

John Johnson, Chief Executive Officer, Melinta Therapeutics Inc

John Johnson at World Anti-Microbial Resistance Congress 2018

Lee Jones, Founder, President and Chief Executive Officer, Rebiotix, Inc.

Lee Jones at World Anti-Microbial Resistance Congress 2018

Mark Jones, Head of Clinical Development and Preclinical Development, Basilea Pharmaceutica Ltd

Mark Jones at World Anti-Microbial Resistance Congress 2018

Patrick Keenan, Managing Director, Prevail Partners

Patrick Keenan at World Anti-Microbial Resistance Congress 2018

Larry Kerr, Co-Chair of TATFAR and Director, Office of Pandemic and Emerging Threats, Office of Global Affairs, Department of Health and Human Services

Larry Kerr at World Anti-Microbial Resistance Congress 2018

Wes Kim, Senior Officer, The Pew Charitable Trusts

Wes Kim at World Anti-Microbial Resistance Congress 2018

Eili Klein, Fellow, Center for Disease Dynamics Economics & Policy

Eili Klein at World Anti-Microbial Resistance Congress 2018

Daniel Knecht, Vice President, Clinical Strategy & Policy, Aetna

Daniel Knecht at World Anti-Microbial Resistance Congress 2018

Jane Knisely, Program Officer, Bacteriology and Mycology Branch, NIAID, NIH

Jane Knisely at World Anti-Microbial Resistance Congress 2018

Jeremy Knox, Policy and Advocacy Lead, Drug-Resistant Infections Programme, Wellcome Trust

Jeremy Knox at World Anti-Microbial Resistance Congress 2018

John Kokai-Kun, Vice President of Non-Clinical Affairs, Synthetic Biologics Inc

John Kokai-Kun at World Anti-Microbial Resistance Congress 2018

Marina Kozark, Health Scientist, BARDA

Marina Kozark at World Anti-Microbial Resistance Congress 2018

Kerry Laplante, President-elect, Society of Infectious Disease Pharmacists

Kerry Laplante at World Anti-Microbial Resistance Congress 2018

Jean-Philippe Lavigne, Clinical Microbiologist, Centre Hospitalier RĂ©gional Universitaire De Nimes

Jean-Philippe Lavigne at World Anti-Microbial Resistance Congress 2018

Colm Leonard, Consultant Clinical Advisor, NICE

Colm Leonard at World Anti-Microbial Resistance Congress 2018

Michael Lobritz, Translational Physician Scientist, Antibiotics, F. Hoffmann-La Roche Ltd

Michael Lobritz at World Anti-Microbial Resistance Congress 2018

Tom Lowery, Chief Scientific Officer, T2 Biosystems Inc

Tom Lowery at World Anti-Microbial Resistance Congress 2018

Nicole Mahoney, Director, Global Regulatory Policy, Merck & Co

Nicole Mahoney at World Anti-Microbial Resistance Congress 2018

Gregory Mario, Chief Executive Officer, TAXIS Pharmaceuticals Inc

Gregory Mario at World Anti-Microbial Resistance Congress 2018

Jill Massey, Senior Vice President, Medical Affairs, Melinta Therapeutics Inc

Jill Massey at World Anti-Microbial Resistance Congress 2018

Pascal Mayer, Chief Executive Officer, Alphanosos S.A.S.

Pascal Mayer at World Anti-Microbial Resistance Congress 2018

Mary Millard, M. Ed, Patient Advocate, Sepsis Survivor

Mary Millard at World Anti-Microbial Resistance Congress 2018

Donald Moir, Chief Scientific Officer, Microbiotix Inc

Donald Moir at World Anti-Microbial Resistance Congress 2018

Cristina Montero, Associate Director, TechAtlas

Cristina Montero at World Anti-Microbial Resistance Congress 2018

Gareth Morgan, SVP, Head, Grobal Portfolio Management, Shionogi Inc

Gareth Morgan at World Anti-Microbial Resistance Congress 2018

Mary Motyl, Director of Clinical Microbiology, Merck & Co

Mary Motyl at World Anti-Microbial Resistance Congress 2018

Steve Nagler, Executive Director, MedPro Investors LLC

Steve Nagler at World Anti-Microbial Resistance Congress 2018

Dave Ousterout, Chief Technology Officer, Locus Biosciences

Dave Ousterout at World Anti-Microbial Resistance Congress 2018

Kevin Outterson, Executive Director, CARB-X

Kevin Outterson at World Anti-Microbial Resistance Congress 2018

Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy, Global Antibiotic Research and Development Partnership (GARDP)

Jean-Pierre Paccaud at World Anti-Microbial Resistance Congress 2018

Rosanna Peeling, Director, International Diagnostics Centre and Chair and Professor of Diagnostic Research, London School of Hygiene and Tropical Medicine

Rosanna Peeling at World Anti-Microbial Resistance Congress 2018

Manos Perros, President & CEO, Entasis Therapeutics

Manos Perros at World Anti-Microbial Resistance Congress 2018

Marie Petit, Coordinator, The Beam Alliance

Marie Petit at World Anti-Microbial Resistance Congress 2018

Yannick Pletan, Acting Chief Medical Officer, Biofilm Pharma

Yannick Pletan at World Anti-Microbial Resistance Congress 2018

John Powers, Team Member of Clinical Trials Transformation Initiative Antibacterial Drug Development Projects and Professor, George Washington University School of Medicine and Health Sciences

John Powers at World Anti-Microbial Resistance Congress 2018

Michael Salter, R&D Facilitator, A.B. Agri

Michael Salter at World Anti-Microbial Resistance Congress 2018

Robert Sambursky, President and Chief Executive Officer, Rapid Pathogen Screening, Inc (RPS)

Robert Sambursky at World Anti-Microbial Resistance Congress 2018

Rangarajan Sampath, Chief Scientific Officer, FIND

Rangarajan Sampath at World Anti-Microbial Resistance Congress 2018

Harshika Sarbajna, Global Head, Anti-infectives, Sandoz International GmbH

Harshika Sarbajna at World Anti-Microbial Resistance Congress 2018

Monika Schneider, Research Associate, Margolis Center for Health Policy, Duke University

Monika Schneider at World Anti-Microbial Resistance Congress 2018

Ted Schroeder, Chief Executive Officer, Nabriva Therapeutics

Ted Schroeder at World Anti-Microbial Resistance Congress 2018

Rajeev Sehgal, Director of Informatics, Becton Dickinson

Rajeev Sehgal at World Anti-Microbial Resistance Congress 2018

Ribhi Shawar, Branch Chief, Division of Microbiology, CDRH OIR FDA

Ribhi Shawar at World Anti-Microbial Resistance Congress 2018

Rick Sibbel, Executive Director and Technical Services, Merck Animal Health

Rick Sibbel at World Anti-Microbial Resistance Congress 2018

Trish Simner, Director of Bacteriology and Parasitology, Division of Medical Microbiology, Johns Hopkins Medical Institutions

Trish Simner at World Anti-Microbial Resistance Congress 2018

Henry Skinner, Senior Vice President, Tekla Capital Management

Henry Skinner at World Anti-Microbial Resistance Congress 2018

Jeff Stein, President and Chief Executive Officer, Cidara Therapeutics

Jeff Stein at World Anti-Microbial Resistance Congress 2018

Leslie Tari, Vice President, Discovery, Cidara Therapeutics

Leslie Tari at World Anti-Microbial Resistance Congress 2018

Pamela Tenaerts, Executive Director, Clinical Trials Transformation Initiative

Pamela Tenaerts at World Anti-Microbial Resistance Congress 2018

Jennifer Townsend, Director of Antimicrobial Stewardship program, Johns Hopkins Bayview Medical Center

Jennifer Townsend at World Anti-Microbial Resistance Congress 2018

Ephraim Tsalik, Associate Professor of Medicine Division of Infectious Diseases, Duke University Medical Center

Ephraim Tsalik at World Anti-Microbial Resistance Congress 2018

Brian Tse, Health Scientist, HHS/BARDA

Brian Tse at World Anti-Microbial Resistance Congress 2018

Fred Turner, Founder & CEO, Shield Diagnostics

Fred Turner at World Anti-Microbial Resistance Congress 2018

Evan Tzanis, Senior Vice President, Chief Development Officer, Paratek Pharmaceuticals

Evan Tzanis at World Anti-Microbial Resistance Congress 2018

Nick Van Hise, Infectious Diseases Clinical Pharmacy Specialist, Research Coordinator, Metro Infectious Disease Consultants

Nick Van Hise at World Anti-Microbial Resistance Congress 2018

Marijn Verhoef, Engagement Manager, Access to Medicine Foundation

Marijn Verhoef at World Anti-Microbial Resistance Congress 2018

Richard Vickers, SVP and CSO, Anti-Infectives, Summit Therapeutics

Richard Vickers at World Anti-Microbial Resistance Congress 2018

Zachary Zimmerman, CEO, Forge Therapeutics

Zachary Zimmerman at World Anti-Microbial Resistance Congress 2018

 

 

DOWNLOAD PROSPECTUS

 

 


GET INVOLVED AT

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Fred Sansiveri
fred.sansiveri@terrapinn.com
+1 646.619.1838

 

 

Press & Media Partnerships

 


Shannon McGorry
shannon.mcgorry@terrapinn.com
+1 646.619.1840

 

 

To Speak

 


Claire Murphy
claire.murphy@terrapinn.com
+1 646.619.1784

 

Sign Up for Event Updates